Real-World Evidence on Treatment Retention, Safety, and Tolerability of Edaravone in Canadian Patients With Amyotrophic Lateral Sclerosis

被引：0
|
作者：
Pham, Dung [1 ]
St-Onge, Louise [1 ]
Ng, Ryan [2 ]
Neish, Calum S. [2 ]
Yap, Belinda [3 ]
Apple, Stephen [4 ]
机构：
[1] Mitsubishi Tanabe Pharma Canada Inc, Toronto, ON, Canada
[2] IQVIA Solut Canada Inc, Toronto, ON, Canada
[3] Innomar Strategies, Oakville, ON, Canada
[4] Mitsubishi Tanabe Pharma Amer, Jersey City, NJ USA
来源：
MUSCLE & NERVE | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
89
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Real-world Evidence of Radicava® (Edaravone) for Amyotrophic Lateral Sclerosis from a National Infusion Center Database in the United States
    Heiman-Patterson, Terry
    Perdrizet, Johnna
    Prosser, Barbara
    Agnese, Wendy
    Apple, Stephen
    NEUROLOGY, 2020, 94 (15)
  • [2] Edaravone for the treatment of amyotrophic lateral sclerosis
    Yoshino, Hiide
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (03) : 185 - 193
  • [3] Edaravone in the treatment of amyotrophic lateral sclerosis
    Kuzma-Kozakiewicz, Magdalena
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2018, 52 (02) : 124 - 128
  • [4] Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis
    Andrews, Jinsy A.
    Jackson, Carlayne E.
    Heiman-Patterson, Terry D.
    Bettica, Paolo
    Brooks, Benjamin Rix
    Pioro, Erik P.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2020, 21 (7-8) : 509 - 518
  • [5] Logistics and safety of edaravone treatment for amyotrophic lateral sclerosis: experience in Argentina
    Quarracino, C.
    Bendersky, M.
    Rey, R.
    Rodriguez, G. E.
    ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1519 - 1523
  • [6] Logistics and safety of edaravone treatment for amyotrophic lateral sclerosis: experience in Argentina
    C. Quarracino
    M. Bendersky
    R. Rey
    G. E. Rodríguez
    Acta Neurologica Belgica, 2021, 121 : 1519 - 1523
  • [7] Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
    Cho, HaEun
    Shukla, Surabhi
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 14
  • [8] Real-world safety of the novel, free radical scavenger edaravone for amyotrophic lateral sclerosis patients: Data from the post-marketing surveillance SUNRISE Japan
    Ishizaki, Kaoru
    Yoshimura, Kenta
    Yoshida, Kengo
    Matsuda, Masao
    Kawaguchi, Yutaka
    Yuki, Satoshi
    Sobue, Gen
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2021, 9 (03): : 223 - 229
  • [9] Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis
    Witzel, Simon
    Maier, Andre
    Steinbach, Robert
    Grosskreutz, Julian
    Koch, Jan C.
    Sarikidi, Anastasia
    Petri, Susanne
    Guenther, Rene
    Wolf, Joachim
    Hermann, Andreas
    Prudlo, Johannes
    Cordts, Isabell
    Lingor, Paul
    Loescher, Wolfgang N.
    Kohl, Zacharias
    Hagenacker, Tim
    Ruckes, Christian
    Koch, Birgit
    Spittel, Susanne
    Guenther, Kornelia
    Michels, Sebastian
    Dorst, Johannes
    Meyer, Thomas
    Ludolph, Albert C.
    JAMA NEUROLOGY, 2022, 79 (02) : 121 - 130
  • [10] A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone
    Sahin, Erdi
    TURKISH JOURNAL OF NEUROLOGY, 2018, 24 (01) : 105 - 106
12345